A new COVID-19 variant, XEC, a sub-lineage of Omicron, has emerged and is causing concern among experts. The variant has been detected in multiple countries, including Europe and the United States, and is exhibiting signs of rapid spread. While symptoms are similar to previous Omicron variants, experts urge vaccination and adherence to hygiene protocols for protection.
Chronic stress can lead to high cortisol levels, impacting your health in various ways. This article explores five key symptoms that indicate high cortisol levels, including weight gain, sleep disturbances, facial changes, slow healing, and bloating. Learn how to recognize these signs and take steps towards managing your stress.
The global market for chemotherapy-induced nausea and vomiting (CINV) treatment is expected to grow significantly in the coming years, reaching a valuation of US$ 12.69 billion by 2034. This growth is driven by the increasing incidence of cancer worldwide, leading to more patients undergoing chemotherapy. CINV is a common side effect of chemotherapy, significantly impacting patients’ quality of life. The development of new and more effective anti-emetic drugs, particularly NK-1 receptor antagonists, is a key factor driving market growth.
Ascendis Pharma’s TransCon CNP, a once-weekly treatment for achondroplasia, demonstrated superior annualized growth velocity compared to placebo in a recent trial. This could pose a significant challenge to BioMarin’s Voxzogo, the current leading treatment for achondroplasia. While BioMarin holds a first-mover advantage, the potential for TransCon CNP’s improved dosing schedule and safety profile could impact Voxzogo’s market share in the coming years.
Tretinoin, a powerful prescription-strength retinoid, offers a plethora of skin benefits, from tackling acne and blemishes to reducing the appearance of wrinkles and dark spots. Gone are the days of long doctor’s appointments, as numerous brands now offer convenient virtual consultations and direct delivery of customized tretinoin formulas. This comprehensive guide explores the top brands, their key ingredients, and expert tips on incorporating tretinoin into your skincare routine for optimal results.
The Kerala government has implemented restrictions in containment zones in Malappuram district after a 24-year-old student succumbed to Nipah virus infection. The measures include early closure of shops, closure of educational institutions, and mandatory mask-wearing in public. The state health minister has released a list of 175 individuals who came into contact with the deceased and is actively monitoring the situation.
Nuvalent, Inc. (NUVL) presented positive data from its Phase 1/2 trials of zidesamtinib (ARROS-1) and NVL-655 (ALKOVE-1) at the European Society for Medical Oncology (ESMO) Congress 2024. The data showcased significant response rates and durable responses in heavily pretreated patients with advanced ROS1-positive and ALK-positive non-small cell lung cancer (NSCLC) and other solid tumors. Nuvalent plans to initiate a Phase 3 study for ALK-positive NSCLC in the first half of 2025.
Psyence Biomedical, a biotechnology company focused on natural psychedelic-based solutions for mental health, has announced significant progress in its clinical trials and partnerships. The company is currently conducting a Phase IIb clinical trial in Australia for psilocybin-assisted therapy for Adjustment Disorder in palliative care and is expanding its pipeline into Substance Use Disorders, particularly Alcohol Use Disorder (AUD). These developments position Psyence for key data readouts in 2025, potentially leading to commercial success.
The FDA has approved Eli Lilly’s Ebglyss (lebrikizumab-lbkz), a targeted IL-13 inhibitor, for adults and children with moderate-to-severe atopic dermatitis (eczema) that doesn’t respond well to topical treatments. Ebglyss targets eczema inflammation throughout the body, leading to significant improvement in skin dryness, itching, and irritation. The drug’s effectiveness was proven in clinical trials, with a substantial percentage of patients achieving clear or almost-clear skin and itch relief.
Influencer Fabiana Justus, diagnosed with Acute Myeloid Leukemia earlier this year, continues to share her journey through treatment following a bone marrow transplant. In recent videos, she updates her followers on her progress, including a new round of tests at the hospital and the challenges she faces with ongoing medication.
